BIG PHARMA WATCH: CEO UNDERCUTS OWN INDUSTRY’S DOOM AND GLOOM RHETORIC ON RECENT DRUG PRICING SOLUTIONS
Sep 22, 2022
Novartis Exec Calls Policy to Keep Price Hikes Below Inflation… Read More
© 2026 CSRXP- All Rights Reserved
Blog Posts
DOSE OF REALITY: BIG PHARMA’S PRICING PRACTICES DRIVE CRISIS OF AFFORDABILITY FOR CANCER PATIENTS
Sep 20, 2022
Shining a Light on How Big Pharma is Rapidly Increasing Prices on Oncology… Read More
BIG PHARMA WATCH: REPORT FINDS BIG PHARMA’S “PERVASIVE” PATENT ABUSE “THE ROOT OF THE DRUG PRICING CRISIS”
Sep 15, 2022
I-MAK Analysis Finds Anti-Competitive Practices That Extend Exclusivity Will… Read More
BIG PHARMA WATCH: STUDY FINDS BIG PHARMA PROFITS THROUGH ANTI-COMPETITIVE KICKBACK SCHEMES CLOAKED AS CHARITY
Sep 9, 2022
Researchers Say Brand Name Drug Companies’ So-Called Patient Assistance… Read More
SECOND OPINION: AVIK ROY DEBUNKS BIG PHARMA’S INNOVATION RHETORIC
Sep 1, 2022
FREOPP President Explains Pharmaceutical Industry Arguments Are “Factually… Read More
DOSE OF REALITY: REPORT FINDS RX SPENDING CONTINUED TO RISE AS BIG PHARMA MAINTAINED BUSINESS-AS-USUAL APPROACH TO PRICE-GOUGING
Sep 1, 2022
Analysis Highlights How Escalating Prescription Drug Costs, Driven By Big… Read More
BIG PHARMA WATCH: DRUG COMPANIES ON PACE FOR RECORD 2022 LAUNCH PRICES
Aug 16, 2022
Analysis Finds Brand Name Manufacturers Bringing New Drugs to Market with… Read More
BIG PHARMA EARNINGS WATCH: ABBVIE, ASTRAZENECA, AMGEN
Aug 5, 2022
Big Pharma Drugmakers Top Wall Street Estimates After Hiking Drug Prices… Read More
SECOND OPINION: PHRMA’S LAST-DITCH ATTEMPT TO DERAIL SOLUTIONS TO LOWER DRUG PRICES REHASHES DEBUNKED ARGUMENTS
Aug 5, 2022
Pharmaceutical Industry Attempts to Intimidate Lawmakers and Keep Prices High… Read More
BIG PHARMA EARNINGS WATCH: PFIZER, MERCK, BRISTOL MYERS SQUIBB, GLAXOSMITHKLINE AND SANOFI
Jul 29, 2022
Big Pharma Giants All Top Analysts’ Expectations as Pharmaceutical Industry… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON, ROCHE, NOVARTIS
Jul 22, 2022
Big Pharma Kicks Off Q2 Earnings Calls After More than 100 Price Hikes to… Read More
SECOND OPINION: BIG PHARMA’S PRICE HIKES HAVE LONG OUTPACED INFLATION
Jul 11, 2022
PhRMA Ads Falsely Claim the Industry’s Egregious Pricing Practices Don’t… Read More